The mission of the new Silab softcare department is to research, produce and market innovative natural active ingredients, specially designed to respond to dermatological disorders, by restoring the homeostasis of healthy skin.
A pioneer in the engineering of natural cosmetic active ingredients, Silab today targets the dermocosmetics and dermatological markets. Silab softcare relies on the expertise, capacity for innovation and responsiveness of the Silab organization to extend the skills developed on healthy skin to the problems of weakened skin.
For more than 5 years, a team of multidisciplinary researchers, associating molecular biologists, bioinformaticians, clinical experts, process engineers, has been deploying the latest generation tools and advanced technologies, from the health sector, to deepen knowledge of eco-systems. skin systems. It has designed an original scientific research program, composed of unprecedented in vitro and in vivo models, validated by the international dermatological community, to offer a product in powder form without preservatives, according to three principles of excellence: efficacy, safety and naturalness. .
The first phase of development of Silab softcare is materialized by the marketing of Ad ‑ Resyl, a patented natural active principle intended for the comfort and resilience of atopic skin. This product prevents the clinical signs of atopic dermatitis by prolonging the periods of remission following corticosteroid therapy. Tested both on cohorts of Caucasian and Asian subjects, children and / or adults, Ad ‑ Resyl meets the many requirements of patients seeking care and comfort to regain the health of their skin: clinically proven efficacy, optimal skin tolerance , controlled natural raw material.
“ Silab is an independent French group that relies on a sustainable strategy of organic growth. Our innovation in beauty care for healthy skin has been recognized worldwide for 30 years and our expertise in skin biology is now pushing us to naturally expand our field of research towards weakened skin. The ambitions of this new department are numerous and other research projects have already been launched (acne, healing, etc.). »Says Brigitte Closs-Gonthier, Deputy Director General for Research, Silab.